OncohematologyOncohematologyОнкогематология1818-83462413-4023Publishing House ABV Press71510.17650/1818-8346-2009-0-1-57-64QUALITY OF LIFE AND FOLLOW-UPКАЧЕСТВО ЖИЗНИ И ДИСПАНСЕРНОЕ НАБЛЮДЕНИЕ ОНКОГЕМАТОЛОГИЧЕСКИХ БОЛЬНЫХVaccination in children with cancerВакцинация детей с онкологическими заболеваниямиKachanovD. Y.КачановД. Ю.
Russian Federation

Moscow; Balashiha

Москва; Балашиха

ShamanskayaT. V.ШаманскаяТ. В.
Russian Federation

Moscow

Москва

AbdullaevR. T.АбдуллаевР. Т.
Russian Federation

Moscow; Balashiha

Москва; Балашиха

DobrenkovK. V.ДобреньковК. В.
Russian Federation

Moscow

Москва

VarfolomeevaS. R.ВарфоломееваС. Р.
Russian Federation

Moscow; Balashiha

Москва; Балашиха

Federal Clinical Research Center of Pediatric Hematology, Oncology and ImmunologyФедеральный научно-клинический центр детской гематологии, онкологии и иммунологии МинздравсоцразвитияMoscow Regional Oncological HospitalМосковский областной онкологический диспансер240220091576424112022241120222009https://oncohematology.abvpress.ru/ongm/article/view/715

In the article the international experience of vaccination in children with cancer receiving standard-dose cancer therapy is presented. Vaccination of children during and after completion of anticancer therapy is discussed. Reduction in immunity to vaccine-preventable diseases after completion of standard-dose chemotherapy that may demand reimmunization is demonstrated.

В статье представлен международный опыт вакцинации детей со злокачественными новообразованиями, получающими немиелоаблативную терапию. Рассмотрены вопросы вакцинации детей как на этапе противоопухолевой терапии, так и после ее окончания. Показано, что в процессе проведения терапии снижается уровень антител к вакцинальным антигенам, в связи с чем может потребоваться проведение ревакцинации.

childrencancervaccinationдетизлокачественные новообразованиявакцинация1. Gatta G., Capocaccia R., Stiller C. et al.; EUROCARE Working Group. Childhood cancer survival trends in Europe: a EUROCARE Working Group study. J Clin Oncol 2005;23(16):3742—51.Gatta G., Capocaccia R., Stiller C. et al.; EUROCARE Working Group. Childhood cancer survival trends in Europe: a EUROCARE Working Group study. J Clin Oncol 2005;23(16):3742—51.2. Feldman S., Gigliotti F., Shenep J.L. et al. Risk of Haemophilus influenzae type b disease in children with cancer and response of immunocompromised leukemic children to a conjugate vaccine. J Infect Dis 1990;161(5):926—31.Feldman S., Gigliotti F., Shenep J.L. et al. Risk of Haemophilus influenzae type b disease in children with cancer and response of immunocompromised leukemic children to a conjugate vaccine. J Infect Dis 1990;161(5):926—31.3. Meisel R., Toschke M., Heiligensetzer C. et al. Increased risk for invasive pneumococcal disease in children with acute lymphoblastic leukaemia. Br J Haematol 2007;137:457—60.Meisel R., Toschke M., Heiligensetzer C. et al. Increased risk for invasive pneumococcal disease in children with acute lymphoblastic leukaemia. Br J Haematol 2007;137:457—60.4. Hjuler T., Wohlfahrt J., Staum K.M. et al. Risks of invasive pneumococcal disease in children with underlying chronic diseases. Pediatrics 2008;122;26—32.Hjuler T., Wohlfahrt J., Staum K.M. et al. Risks of invasive pneumococcal disease in children with underlying chronic diseases. Pediatrics 2008;122;26—32.5. Arvin A.M. Antiviral therapy for varicella and herpes zoster. Semin Pediatr Infect Dis 2002;13(1):12—21.Arvin A.M. Antiviral therapy for varicella and herpes zoster. Semin Pediatr Infect Dis 2002;13(1):12—21.6. Kaplan L.J., Daum R.S., Smaron M. et al. Severe measles in immunocompromised patients. JAMA 1992;267:1237—41.Kaplan L.J., Daum R.S., Smaron M. et al. Severe measles in immunocompromised patients. JAMA 1992;267:1237—41.7. Price V.E., Dutta S., Blanchette V.S. et al. The prevention and treatment of bacterial infections in children with asplenia or hyposplenia: practice considerations at the Hospital for Sick Children, Toronto. Pediatr Blood Cancer 2006;46(5):597—603.Price V.E., Dutta S., Blanchette V.S. et al. The prevention and treatment of bacterial infections in children with asplenia or hyposplenia: practice considerations at the Hospital for Sick Children, Toronto. Pediatr Blood Cancer 2006;46(5):597—603.8. Reinhardt D., Houliara K., Pekrun A. et al. Impact of conventional chemotherapy on levels of antibodies against vaccinepreventable diseases in children treated for cancer. Scand J Infect Dis 2003;35(11—12):851—7.Reinhardt D., Houliara K., Pekrun A. et al. Impact of conventional chemotherapy on levels of antibodies against vaccinepreventable diseases in children treated for cancer. Scand J Infect Dis 2003;35(11—12):851—7.9. Ercan T.E., Soycan L.Y., Apak H. et al. Antibody titers and immune response to diphtheria-tetanus-pertussis and measlesmumps-rubella vaccination in children treated for acute lymphoblastic leukemia. J Pediatr Hematol Oncol 2005;27(5):273—7.Ercan T.E., Soycan L.Y., Apak H. et al. Antibody titers and immune response to diphtheria-tetanus-pertussis and measlesmumps-rubella vaccination in children treated for acute lymphoblastic leukemia. J Pediatr Hematol Oncol 2005;27(5):273—7.10. Patel S.R., Chisholm J.C., Heath P.T. Vaccinations in children treated with standard-dose cancer therapy or hematopoietic stem cell transplantation. Pediatr Clin North Am 2008;55(1):169—86.Patel S.R., Chisholm J.C., Heath P.T. Vaccinations in children treated with standard-dose cancer therapy or hematopoietic stem cell transplantation. Pediatr Clin North Am 2008;55(1):169—86.11. Chisholm J.C. Reimmunization after therapy for childhood cancer. Clin Infect Dis 2007;44(5):643—5.Chisholm J.C. Reimmunization after therapy for childhood cancer. Clin Infect Dis 2007;44(5):643—5.12. Allen U.D. Immunizations for children with cancer. Pediatr Blood Cancer 2007;49(7 Suppl):1102—8.Allen U.D. Immunizations for children with cancer. Pediatr Blood Cancer 2007;49(7 Suppl):1102—8.13. Alanko S., Pelliniemi T.T., Salmi T.T. Recovery of blood B-lymphocytes and serum immunoglobulins after chemotherapy for childhood acute lymphoblastic leukemia. Cancer 1992;69(6):1481—6.Alanko S., Pelliniemi T.T., Salmi T.T. Recovery of blood B-lymphocytes and serum immunoglobulins after chemotherapy for childhood acute lymphoblastic leukemia. Cancer 1992;69(6):1481—6.14. Alanko S., Salmi T.T., Pelliniemi T.T. Recovery of blood T-cell subsets after chemotherapy for childhood acute lymphoblastic leukemia. Pediatr Hematol Oncol 1994;11(3):281—92.Alanko S., Salmi T.T., Pelliniemi T.T. Recovery of blood T-cell subsets after chemotherapy for childhood acute lymphoblastic leukemia. Pediatr Hematol Oncol 1994;11(3):281—92.15. Alanko S., Salmi T.T., Pelliniemi T.T. Recovery of natural killer cells after chemotherapy for childhood acute lymphoblastic leukemia and solid tumors. Med Pediatr Oncol 1995;24(6):373—8.Alanko S., Salmi T.T., Pelliniemi T.T. Recovery of natural killer cells after chemotherapy for childhood acute lymphoblastic leukemia and solid tumors. Med Pediatr Oncol 1995;24(6):373—8.16. Ek T., Mellander L., Andersson B., Abrahamsson J. Immune reconstitution after childhood acute lymphoblastic leukemia is most severely affected in the high risk group. Pediatr Blood Cancer 2005;44(5):461—8.Ek T., Mellander L., Andersson B., Abrahamsson J. Immune reconstitution after childhood acute lymphoblastic leukemia is most severely affected in the high risk group. Pediatr Blood Cancer 2005;44(5):461—8.17. Mustafa M.M., Buchanan G.R., Winick N.J. et al. Immune recovery in children with malignancy after cessation of chemotherapy. J Pediatr Hematol Oncol 1998;20(5):451—7.Mustafa M.M., Buchanan G.R., Winick N.J. et al. Immune recovery in children with malignancy after cessation of chemotherapy. J Pediatr Hematol Oncol 1998;20(5):451—7.18. Alanko S., Pelliniemi T.T., Salmi T.T. Recovery of blood lymphocytes and serum immunoglobulins after treatment of solid tumors in children. Pediatr Hematol Oncol 1994;11(1):33—45.Alanko S., Pelliniemi T.T., Salmi T.T. Recovery of blood lymphocytes and serum immunoglobulins after treatment of solid tumors in children. Pediatr Hematol Oncol 1994;11(1):33—45.19. Zignol M., Peracchi M., Tridello G. et al. Assessment of humoral immunity to poliomyelitis, tetanus, hepatitis B, measles, rubella, and mumps in children after chemotherapy. Cancer 2004;101:635—41.Zignol M., Peracchi M., Tridello G. et al. Assessment of humoral immunity to poliomyelitis, tetanus, hepatitis B, measles, rubella, and mumps in children after chemotherapy. Cancer 2004;101:635—41.20. Nilsson A., De Milito A., Engstrцm P. et al. Current chemotherapy protocols for childhood acute lymphoblastic leukemia induce loss of humoral immunity to viral vaccination antigens. Pediatrics 2002;109(6):91.Nilsson A., De Milito A., Engstrцm P. et al. Current chemotherapy protocols for childhood acute lymphoblastic leukemia induce loss of humoral immunity to viral vaccination antigens. Pediatrics 2002;109(6):91.21. Van Tilburg C.M., Sanders E.A., Rovers M.M. et al. Loss of antibodies and response to (re-) vaccination in children after treatment for acute lymphocytic leukemia: a systematic review. Leukemia 2006;20(10):1717—22.Van Tilburg C.M., Sanders E.A., Rovers M.M. et al. Loss of antibodies and response to (re-) vaccination in children after treatment for acute lymphocytic leukemia: a systematic review. Leukemia 2006;20(10):1717—22.22. Feldman S., Andrew M., Norris B. et al. Decline in rates of seropositivity for measles, mumps, and rubella antibodies among previously immunised children treated for acute leukaemia. Clin Infect Dis 1998;27:388—90.Feldman S., Andrew M., Norris B. et al. Decline in rates of seropositivity for measles, mumps, and rubella antibodies among previously immunised children treated for acute leukaemia. Clin Infect Dis 1998;27:388—90.23. Yu J., Chou A.J., Lennox A. et al. Loss of antibody titers and effectiveness of revaccination in post-chemotherapy pediatric sarcoma patients. Pediatr Blood Cancer 2007;49(5):656—60.Yu J., Chou A.J., Lennox A. et al. Loss of antibody titers and effectiveness of revaccination in post-chemotherapy pediatric sarcoma patients. Pediatr Blood Cancer 2007;49(5):656—60.24. Schuller E., Fцrster-Waldl E., Slavc I., Maurer W. Immunity against vaccine-preventable potentially neurotropic diseases in children treated for malignant brain tumours with HIT-91 chemo- and radiotherapy. Eur J Cancer 2004;40(2):236—44.Schuller E., Fцrster-Waldl E., Slavc I., Maurer W. Immunity against vaccine-preventable potentially neurotropic diseases in children treated for malignant brain tumours with HIT-91 chemo- and radiotherapy. Eur J Cancer 2004;40(2):236—44.25. Fioredda F., Plebani A., Hanau G. et al. Re-immunisation schedule in leukaemic children after intensive chemotherapy: a possible stratergy. Eur J Haematol 2005;74:20—3.Fioredda F., Plebani A., Hanau G. et al. Re-immunisation schedule in leukaemic children after intensive chemotherapy: a possible stratergy. Eur J Haematol 2005;74:20—3.26. Patel S.R., Ortin M., Cohen B.J. et al. Revaccination of children after completion of standard chemotherapy for acute leukemia. Clin Infect Dis 2007;44(5):635—42.Patel S.R., Ortin M., Cohen B.J. et al. Revaccination of children after completion of standard chemotherapy for acute leukemia. Clin Infect Dis 2007;44(5):635—42.27. Calaminus G., Hense B., Laws H.J. et al. Diphtheria (D) and tetanus (T) antibody values in children with acute lymphoblastic leukaemia (ALL) after treatment according to Co-ALL 05/92. Klin Pediatr 2007;219(6):355—60.Calaminus G., Hense B., Laws H.J. et al. Diphtheria (D) and tetanus (T) antibody values in children with acute lymphoblastic leukaemia (ALL) after treatment according to Co-ALL 05/92. Klin Pediatr 2007;219(6):355—60.28. Ek T., Mellander L., Hahn-Zoric M., Abrahamsson J. Intensive treatment for childhood acute lymphoblastic leukemia reduces immune responses to diphtheria, tetanus, and Haemophilus influenzae type b. J Pediatr Hematol Oncol 2004;26(11):727—34.Ek T., Mellander L., Hahn-Zoric M., Abrahamsson J. Intensive treatment for childhood acute lymphoblastic leukemia reduces immune responses to diphtheria, tetanus, and Haemophilus influenzae type b. J Pediatr Hematol Oncol 2004;26(11):727—34.29. Cheng F.W., Leung T.F., Chan P.K. et al. Humoral immune response after post-chemotherapy booster diphtheriatetanus-pertussis vaccine in pediatric oncology patients. Pediatr Blood Cancer 2009;52(2):248—53.Cheng F.W., Leung T.F., Chan P.K. et al. Humoral immune response after post-chemotherapy booster diphtheriatetanus-pertussis vaccine in pediatric oncology patients. Pediatr Blood Cancer 2009;52(2):248—53.30. Royal College of Paediatrics and Child Health. Immunisation of the immunocompromised child, best practice statement. United Kingdom: Royal College of Paediatrics and Child Health, 2002.Royal College of Paediatrics and Child Health. Immunisation of the immunocompromised child, best practice statement. United Kingdom: Royal College of Paediatrics and Child Health, 2002.31. Australian immunisation handbook. Draft 9th edition 2009, NHMRC. Available from: http://www.immunise.health.gov.au/internet/immunise/publishing.nsf/Content/Handbook-home [access 07.01. 2009].Australian immunisation handbook. Draft 9th edition 2009, NHMRC. Available from: http://www.immunise.health.gov.au/internet/immunise/publishing.nsf/Content/Handbook-home [access 07.01. 2009].32. Recommendations of the Advisory Committee on Immunization Practices (ACIP): use of vaccines and immune globulins for persons with altered immunocompetence. MMWR Recomm Rep 1993;42(RR-4):1—18.Recommendations of the Advisory Committee on Immunization Practices (ACIP): use of vaccines and immune globulins for persons with altered immunocompetence. MMWR Recomm Rep 1993;42(RR-4):1—18.33. Hovi L., Valle M., Siimes M.A. et al. Impaired response to hepatitis B vaccine in children receiving anticancer chemotherapy. Pediatr Infect Dis J 1995;14(11):931—5.Hovi L., Valle M., Siimes M.A. et al. Impaired response to hepatitis B vaccine in children receiving anticancer chemotherapy. Pediatr Infect Dis J 1995;14(11):931—5.34. Kroger A.T., Atkinson W.L., Marcuse E.K., Pickering L.K.; Advisory Committee on Immunization Practices (ACIP) Centers for Disease Control and Prevention (CDC). General recommendations on immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2006;55(RR-15):1—48.Kroger A.T., Atkinson W.L., Marcuse E.K., Pickering L.K.; Advisory Committee on Immunization Practices (ACIP) Centers for Disease Control and Prevention (CDC). General recommendations on immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2006;55(RR-15):1—48.35. Cooksley C.D., Avritscher E.B., Bekele B.N. et al. Epidemiology and outcomes of serious influenza-related infections in the cancer population. Cancer 2005;104(3):618—28.Cooksley C.D., Avritscher E.B., Bekele B.N. et al. Epidemiology and outcomes of serious influenza-related infections in the cancer population. Cancer 2005;104(3):618—28.36. Matsuzaki A., Suminoe A., Koga Y. et al. Immune response after influenza vaccination in children with cancer. Pediatr Blood Cancer 2005;45(6):831—7.Matsuzaki A., Suminoe A., Koga Y. et al. Immune response after influenza vaccination in children with cancer. Pediatr Blood Cancer 2005;45(6):831—7.37. Porter C.C., Edwards K.M., Zhu Y., Frangoul H. Immune responses to influenza immunization in children receiving maintenance chemotherapy for acute lymphoblastic leukemia. Pediatr Blood Cancer 2004;42(1):36—40.Porter C.C., Edwards K.M., Zhu Y., Frangoul H. Immune responses to influenza immunization in children receiving maintenance chemotherapy for acute lymphoblastic leukemia. Pediatr Blood Cancer 2004;42(1):36—40.38. Chisholm J.C., Devine T., Charlett A. et al. Response to influenza immunisation during treatment for cancer. Arch Dis Child 2001;84(6):496—500.Chisholm J.C., Devine T., Charlett A. et al. Response to influenza immunisation during treatment for cancer. Arch Dis Child 2001;84(6):496—500.39. LaRussa P., Steinberg S., Gershon A.A. Varicella vaccine for immunocompromised children: results of collaborative studies in the United States and Canada. J Infect Dis 1996;174(Suppl 3):320—3.LaRussa P., Steinberg S., Gershon A.A. Varicella vaccine for immunocompromised children: results of collaborative studies in the United States and Canada. J Infect Dis 1996;174(Suppl 3):320—3.40. Leung T.F., Li C.K., Hung E.C. et al. Immunogenicity of a two-dose regime of varicella vaccine in children with cancers. Eur J Haematol 2004;72(5):353—7.Leung T.F., Li C.K., Hung E.C. et al. Immunogenicity of a two-dose regime of varicella vaccine in children with cancers. Eur J Haematol 2004;72(5):353—7.41. Levin M.J. Varicella vaccination of immunocompromised children. J Infect Dis 2008;197(Suppl 2):200—6.Levin M.J. Varicella vaccination of immunocompromised children. J Infect Dis 2008;197(Suppl 2):200—6.42. National Advisory Committee on Immunization, Health Canada. Canadian Immunization Guide 7th edition 2006 www.naci.gc.ca [access 07.01. 2009].National Advisory Committee on Immunization, Health Canada. Canadian Immunization Guide 7th edition 2006 www.naci.gc.ca [access 07.01. 2009].43. American Academy of Pediatrics Immunization in Special Clinical Circumstances. In: Pickering L.K., Baker C.J., Long S.S., McMillan J.A., eds. Red book: 2006 report of the committee on infectious diseases, 27th edition. Elk Grove Village, IL: American Academy of Pediatrics.American Academy of Pediatrics Immunization in Special Clinical Circumstances. In: Pickering L.K., Baker C.J., Long S.S., McMillan J.A., eds. Red book: 2006 report of the committee on infectious diseases, 27th edition. Elk Grove Village, IL: American Academy of Pediatrics.44. Fioredda F., Cavillo M., Banov L. et al. Immunization after the elective end of antineoplastic chemotherapy in children. Pediatr Blood Cancer 2009;52(2):165—8.Fioredda F., Cavillo M., Banov L. et al. Immunization after the elective end of antineoplastic chemotherapy in children. Pediatr Blood Cancer 2009;52(2):165—8.45. Ridgway D., Wolff L.J., Deforest A. Immunization response varies with intensity of acute lymphoblastic leukemia therapy. Am J Dis Child 1991;145(8):887—91.Ridgway D., Wolff L.J., Deforest A. Immunization response varies with intensity of acute lymphoblastic leukemia therapy. Am J Dis Child 1991;145(8):887—91.46. Mahajan A., English M.W., Jenney M.E. et al. Survey of immunization practices in the United Kingdom during and following completion of anti-cancer chemotherapy in children. Med Pediatr Oncol 2003;40:270—1.Mahajan A., English M.W., Jenney M.E. et al. Survey of immunization practices in the United Kingdom during and following completion of anti-cancer chemotherapy in children. Med Pediatr Oncol 2003;40:270—1.47. Crawford N.W., Heath J.A., Buttery J.P. Immunisation practice of paediatric oncologists: An Australasian survey. J Paediatr Child Health 2007;43:593—6.Crawford N.W., Heath J.A., Buttery J.P. Immunisation practice of paediatric oncologists: An Australasian survey. J Paediatr Child Health 2007;43:593—6.48. Шамшева О.В, Осипова М.А., Поляков В.Г. Форсифицированная вакцинация против гепатита В детей со злокачественными опухолями. Детс инфекц 2003;4:10—3.Шамшева О.В, Осипова М.А., Поляков В.Г. Форсифицированная вакцинация против гепатита В детей со злокачественными опухолями. Детс инфекц 2003;4:10—3.49. Осипова М.А. Форсифицированная вакцинация против гепатита В детей с солидными злокачественными опухолями на фоне полихимиотерапии. Автореф. дис. … канд. мед. Наук. М., 2007.Осипова М.А. Форсифицированная вакцинация против гепатита В детей с солидными злокачественными опухолями на фоне полихимиотерапии. Автореф. дис. … канд. мед. Наук. М., 2007.50. Карпочева С.В. Вакцинация против дифтерии и столбняка детей, имеющих в анамнезе солидные опухоли. Автореф. дис. … канд. мед. наук. М., 1998.Карпочева С.В. Вакцинация против дифтерии и столбняка детей, имеющих в анамнезе солидные опухоли. Автореф. дис. … канд. мед. наук. М., 1998.51. Guidelines for the prevention and treatment of infection in patients with an absent or dysfunctional spleen. Working Party of the British Committee for Standards in Haematology Clinical Haematology Task Force. BMJ 1996;312(7028):430—4.Guidelines for the prevention and treatment of infection in patients with an absent or dysfunctional spleen. Working Party of the British Committee for Standards in Haematology Clinical Haematology Task Force. BMJ 1996;312(7028):430—4.52. Castagnola E., Fioredda F. Prevention of life-threatening infections due to encapsulated bacteria in children with hyposplenia or asplenia: a brief review of current recommendations for practical purposes. Eur J Haematol 2003;71(5):319—26.Castagnola E., Fioredda F. Prevention of life-threatening infections due to encapsulated bacteria in children with hyposplenia or asplenia: a brief review of current recommendations for practical purposes. Eur J Haematol 2003;71(5):319—26.53. Hastings C. Immunization. In: Altman A.J. ed. Supportive care of children with cancer: current therapy and guidelines from the Children's Oncology Group, 3d ed. The Johns Hopkins University Press, 2004. p. 13—24.Hastings C. Immunization. In: Altman A.J. ed. Supportive care of children with cancer: current therapy and guidelines from the Children's Oncology Group, 3d ed. The Johns Hopkins University Press, 2004. p. 13—24.54. Cherif H., Landgren O., Konradsen H.B. et al. Poor antibody response to pneumococcal polysaccharide vaccination suggests increased susceptibility to pneumococcal infection in splenectomized patients with hematological diseases. Vaccine 2006;24(1): 75—81.Cherif H., Landgren O., Konradsen H.B. et al. Poor antibody response to pneumococcal polysaccharide vaccination suggests increased susceptibility to pneumococcal infection in splenectomized patients with hematological diseases. Vaccine 2006;24(1): 75—81.55. Golden E., Beach B., Hastings C. The pediatrician and medical care of the child with cancer. Pediatr Clin North Am 2002;49(6):1319—38.Golden E., Beach B., Hastings C. The pediatrician and medical care of the child with cancer. Pediatr Clin North Am 2002;49(6):1319—38.56. Timitilli A., Bertoluzzo L., Micalizzi C. et al. Anti-varicella-zoster vaccination in contacts of children receiving antineoplastic chemotherapy: a prospective pilot study. Infez Med 2008;16(3):144—7.Timitilli A., Bertoluzzo L., Micalizzi C. et al. Anti-varicella-zoster vaccination in contacts of children receiving antineoplastic chemotherapy: a prospective pilot study. Infez Med 2008;16(3):144—7.57. Kappagoda C., Shaw P., Burgess M. et al. Varicella vaccine in non-immune household contacts of children with cancer or leukaemia. J Paediatr Child Health 1999;35(4):341—5.Kappagoda C., Shaw P., Burgess M. et al. Varicella vaccine in non-immune household contacts of children with cancer or leukaemia. J Paediatr Child Health 1999;35(4):341—5.